TyraTech, Inc. U.S. Registration of New Insect Repellent Product (9471Q)
November 13 2012 - 2:01AM
UK Regulatory
TIDMTYR TIDMTYRU
RNS Number : 9471Q
TyraTech, Inc.
13 November 2012
TyraTech, Inc.
(the "Company" or "TyraTech")
TyraTech Announces U.S. Registration of New Insect Repellent
Product NO-SKEETO!(TM)
Field Trials Demonstrate Superior Performance Over Current
Market Leading Products
TyraTech, Inc. (AIM: TYR and TYRU), a natural life sciences
company, is pleased to announce that the Company has been granted
registration for its new personal insect repellent NO-SKEETO!(TM)
in 49 States and the District of Columbia. This means that the
product is approved and ready for immediate commercialization in
retail channels. NO-SKEETO!(TM) features TyraTech's Nature's
Technology(TM) platform which harnesses the power of natural
ingredients to deliver best-in-class efficacy and family
safety.
Both Laboratory and Field trials have demonstrated that
NO-SKEETO!(TM) significantly outperforms 15% DEET for both mosquito
and tick repellency. Trials have been carried out using various
species of mosquito including those which are known vectors of West
Nile Virus, Malaria, Dengue fever, yellow fever and St Louis
encephalitis. Tick trials have included species which are vectors
for Lyme disease, Rocky Mountain spotted fever and Southern tick
associated rash infection (STARI).
The Company is currently in the process of evaluating global
commercial and retail partners for this product.
The Company has also filed for patent protection for its
NO-SKEETO!(TM) formulation and has submitted data from the
laboratory and field trials for publication in two international
journals.
TyraTech's Vice President of Research & Development, Dr.
Keith Kennedy, said: "Diseases transmitted by mosquitoes and ticks
continue to be an increasing problem in North America. The number
of West Nile Virus cases reported in the US so far this year was
the highest number recorded by the Centers for Disease Control in
the last 10 years and the incidence of Lyme disease continues to
exceed more than 30,000 cases per year. We are excited that we have
been able to develop a highly effective natural alternative to the
products currently available without the unwelcome side effects
associated with DEET. This also further evidences TyraTech's
ability to turn its technology platform into exciting and, what we
believe to be, high value products".
TyraTech's Vice President of Commercial Operations, Shayne
Wetherall, added: "NO-SKEETO!(TM) provides a compelling and timely
solution for families seeking superior non-toxic protection. This
product also provides TyraTech with outstanding commercial
opportunities as it is ready for immediate commercialisation. We
are currently in the process of evaluating global commercial and
retail partners for this product and for our strong pipeline of
personal repellent solutions".
Further information on NO-SKEETO!(TM) is available on the
Company's website at www.tyratech.com/RepellentTechnologyOverview
and www.tyratech.com/HeadLiceTechnologyOverview
###
For further information please contact:
TyraTech Inc.
Alan Reade, Executive Chairman
Tel: +1 919 415 4310
Peter Jerome, Chief Financial Officer
Tel: +1 919 415 4280
N+1 Singer, Nominated Adviser and Joint Broker
Aubrey Powell / Alex Wright
Tel: +44 20 7496 3000
First Columbus LLP, Joint Broker
Chris Crawford
Tel: +44 20 3002 2070
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCFFDEDEFESEFF
Tyratech (LSE:TYR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Tyratech (LSE:TYR)
Historical Stock Chart
From Jul 2023 to Jul 2024
